Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway

Qi Sun(First Affiliated Hospital of Xi'an Jiaotong University), Fanni Li(First Affiliated Hospital of Xi'an Jiaotong University), Zhihua Lü(Shandong University), Dong Xue(Dalian Institute of Chemical Physics), Junjun She(First Affiliated Hospital of Xi'an Jiaotong University), Yanpeng Zhang(Anhui Agricultural University), Huayu Xia(Xi'an Jiaotong University)
Cells
June 30, 2022
10.3390/cells11132078
Cited by 19

Related Papers

Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2019|150
ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome
|Cellular and Molecular Immunology|2019|115
Ultrafine Nickel Nanoparticles Encapsulated in N-Doped Carbon Promoting Hydrogen Oxidation Reaction in Alkaline Media
|ACS Catalysis|2021|99
Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells
|Biochemistry and Cell Biology|2012|62
Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway
|Toxicology Letters|2012|62